Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea.
Saved in:
| Title: | Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea. |
|---|---|
| Authors: | Loder EW; Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Robbins MS; Jack D. Weiler Hospital, Montefiore Medical Center, Inpatient Services, Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, New York. |
| Source: | JAMA [JAMA] 2018 May 15; Vol. 319 (19), pp. 1985-1987. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2018.4852 |